Literature DB >> 33166063

Poirier-Bienvenu neurodevelopmental syndrome: A report of a patient with a pathogenic variant in CSNK2B with abnormal linear growth.

Pavalan Selvam1, Angita Jain1, Anvir Cheema1, Herjot Atwal1, Irman Forghani2, Paldeep S Atwal1.   

Abstract

Casein kinase 2-related disorders have been linked to pathogenic variants in CSNK2A1 and CSNK2B. CSNK2B-related disease is predominantly associated with neurodevelopmental abnormalities affecting cognition; however, the extent of the phenotype associated with CSNK2B pathogenic variants is yet to be fully explored. Here, we describe a patient with features suggestive of Poirier-Bienvenu neurodevelopmental syndrome, harboring a novel CSNK2B pathogenic variant. We also report that the linear growth abnormalities could be a recurrent presentation in patients with this syndrome and suggest the effect of growth hormone therapy in our patient's stature.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  CSNK2B; dopamine; intellectual disability; seizures; stature

Mesh:

Substances:

Year:  2020        PMID: 33166063     DOI: 10.1002/ajmg.a.61960

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  De novo variants of CSNK2B cause a new intellectual disability-craniodigital syndrome by disrupting the canonical Wnt signaling pathway.

Authors:  Maria Asif; Emrah Kaygusuz; Marwan Shinawi; Anna Nickelsen; Tzung-Chien Hsieh; Prerana Wagle; Birgit S Budde; Jennifer Hochscherf; Uzma Abdullah; Stefan Höning; Christian Nienberg; Dirk Lindenblatt; Angelika A Noegel; Janine Altmüller; Holger Thiele; Susanne Motameny; Nicole Fleischer; Idan Segal; Lynn Pais; Sigrid Tinschert; Nadra Nasser Samra; Juliann M Savatt; Natasha L Rudy; Chiara De Luca; Susan M White; Peter Krawitz; Anna C E Hurst; Karsten Niefind; Joachim Jose; Francesco Brancati; Peter Nürnberg; Muhammad Sajid Hussain
Journal:  HGG Adv       Date:  2022-04-18

2.  Genetic Diagnosis in Children with Epilepsy and Developmental Disorders by Targeted Gene Panel Analysis in a Developing Country.

Authors:  Md Mizanur Rahman; Kanij Fatema
Journal:  J Epilepsy Res       Date:  2021-06-30

3.  Two different presentations of de novo variants of CSNK2B: two case reports.

Authors:  Matheus V M B Wilke; Bibiana M Oliveira; Alessandra Pereira; Maria Juliana R Doriqui; Fernando Kok; Carolina F M Souza
Journal:  J Med Case Rep       Date:  2022-01-05

4.  Expanding Phenotype of Poirier-Bienvenu Syndrome: New Evidence from an Italian Multicentrical Cohort of Patients.

Authors:  Alessandro Orsini; Andrea Santangelo; Francesca Bravin; Alice Bonuccelli; Diego Peroni; Roberta Battini; Thomas Foiadelli; Veronica Bertini; Angelo Valetto; Michele Iacomino; Vincenzo Nigro; Anna Laura Torella; Marcello Scala; Valeria Capra; Maria Stella Vari; Anna Fetta; Veronica Di Pisa; Francesca Montanari; Roberta Epifanio; Paolo Bonanni; Roberto Giorda; Francesca Operto; Grazia Pastorino; Esra Sarigecili; Esra Sardaroglu; Cetin Okuyaz; Sevgan Bozdogan; Luciana Musante; Flavio Faletra; Caterina Zanus; Alessandro Ferretti; Federico Vigevano; Pasquale Striano; Duccio Maria Cordelli
Journal:  Genes (Basel)       Date:  2022-01-30       Impact factor: 4.096

5.  De Novo CSNK2B Mutations in Five Cases of Poirier-Bienvenu Neurodevelopmental Syndrome.

Authors:  Qi Yang; Qinle Zhang; Shang Yi; Zailong Qin; Fei Shen; Shang Ou; Jingsi Luo; Sheng He
Journal:  Front Neurol       Date:  2022-03-16       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.